Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients

Annika M. A. Berends; Mathieu S. Bolhuis; Ilja M. Nolte; Edward Buitenwerf; Thera P. Links; Henri J. L. M. Timmers; Richard A. Feelders; Elisabeth M. W. Eekhoff; Eleonora P. M. Corssmit; Peter H. Bisschop; Harm R. Haak; Ron H. N. van Schaik; Samira el Bouazzaoui; Bob Wilffert; Michiel N. Kerstens

doi:10.3390/biomedicines10040896

Biomedicines (Apr 2022)

Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients

Annika M. A. Berends,
Mathieu S. Bolhuis,
Ilja M. Nolte,
Edward Buitenwerf,
Thera P. Links,
Henri J. L. M. Timmers,
Richard A. Feelders,
Elisabeth M. W. Eekhoff,
Eleonora P. M. Corssmit,
Peter H. Bisschop,
Harm R. Haak,
Ron H. N. van Schaik,
Samira el Bouazzaoui,
Bob Wilffert,
Michiel N. Kerstens

Affiliations

Annika M. A. Berends: Department of Endocrinology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
Mathieu S. Bolhuis: Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands
Ilja M. Nolte: Department of Epidemiology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands
Edward Buitenwerf: Department of Endocrinology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
Thera P. Links: Department of Endocrinology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
Henri J. L. M. Timmers: Department of Internal Medicine, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
Richard A. Feelders: Department of Endocrinology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
Elisabeth M. W. Eekhoff: Department of Internal Medicine Section Endocrinology, Amsterdam University Medical Centers Location VUmc, 1117 HV Amsterdam, The Netherlands
Eleonora P. M. Corssmit: Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
Peter H. Bisschop: Department of Internal Medicine Section Endocrinology, Amsterdam University Medical Centers Location AMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
Harm R. Haak: Department of Internal Medicine, Máxima Medical Center, 5504 DB Eindhoven/Veldhoven, The Netherlands
Ron H. N. van Schaik: Department of Clinical Chemistry, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
Samira el Bouazzaoui: Department of Clinical Chemistry, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
Bob Wilffert: Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands
Michiel N. Kerstens: Department of Endocrinology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands

DOI: https://doi.org/10.3390/biomedicines10040896
Journal volume & issue: Vol. 10, no. 4
p. 896

Abstract

Read online

Background: Presurgical treatment with an α-adrenergic receptor blocker is recommended to antagonize the catecholamine-induced α-adrenergic receptor mediated vasoconstriction in patients with pheochromocytoma or sympathetic paraganglioma (PPGL). There is, however, a considerable interindividual variation in the dose-response relationship regarding the magnitude of blood pressure reduction or the occurrence of side effects. We hypothesized that genetically determined differences in α-adrenergic receptor activity contribute to this variability in dose-response relationship. Methods: Thirty-one single-nucleotide polymorphisms (SNPs) of the α1A, α1B, α1D adrenoreceptor (ADRA1A, ADRA1B, ADRA1D) and α2A, α2B adrenoreceptor (ADRA2A, ADRA2B) genes were genotyped in a group of 116 participants of the PRESCRIPT study. Haplotypes were constructed after determining linkage disequilibrium blocks. Results: The ADRA1B SNP rs10515807 and the ADRA2A SNPs rs553668/rs521674 were associated with higher dosages of α-adrenergic receptor blocker (p p = 0.005). Similar associations were found for haplotype block 6, which is predominantly defined by rs10515807. Conclusions: This study suggests that genetic variability of α-adrenergic receptor genes might be associated with the clinically observed variation in beneficial and adverse therapeutic drug responses to α-adrenergic receptor blockers. Further studies in larger cohorts are needed to confirm our observations.

Published in Biomedicines

ISSN: 2227-9059 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Science: Biology (General)
Website: http://www.mdpi.com/journal/biomedicines

About the journal

Abstract

Keywords